Multi-specialty hospital group operating owned/operated hospitals across India, the UK and Cayman Islands
Price
Market Cap
Sector
Healthcare
Rank
| Line item | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 | FY26 |
|---|---|---|---|---|---|---|---|---|
| LiabilitiesEquity Capital | 204 | 204 | 204 | 204 | 204 | 204 | 204 | 204 |
| Reserves | 932 | 916 | 1.3k | 1.9k | 2.7k | 3.4k | 3.9k | 4.3k |
| Borrowings | 952 | 826 | 723 | 884 | 1.6k | 2.4k | 2.3k | 5.9k |
| Other Liabilities | 813 | 833 | 931 | 1.2k | 1.1k | 1.2k | 1.3k | 2.1k |
| Total Liabilities | 2.9k | 2.8k | 3.1k | 4.2k | 5.6k | 7.3k | 7.7k | 12.5k |
| AssetsFixed Assets | 2.1k | 2.0k | 2.0k | 2.3k | 2.7k | 4.3k | 4.4k | 7.8k |
| CWIP | 12 | 20 | 67 | 259 | 514 | 86 | 135 | 292 |
| Investments | 86 | 120 | 132 | 252 | 844 | 1.1k | 1.4k | 573 |
| Other Assets | 711 | 678 | 964 | 1.3k | 1.6k | 1.8k | 1.8k | 3.8k |
| Total Assets | 2.9k | 2.8k | 3.1k | 4.2k | 5.6k | 7.3k | 7.7k | 12.5k |
| Line item | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|
| ActivitiesCash from Operating | 279 | 443 | 304 | 485 | 1.1k | 1.1k | 986 | 1.6k |
| Cash from Investing | -162 | -189 | -113 | -267 | -1.2k | -1.5k | -1.3k | -3.6k |
| Cash from Financing | -27 | -247 | -194 | -159 | 88 | 488 | 544 | 2.3k |
| SummaryCapital Expenditure | — | — | — | — | — | — | — | — |
| Free Cash Flow | 129 | 329 | 235 | 235 | 563 | 99 | -93 | 753 |
| FCF Margin | — | — | — | — | — | — | — | — |
The Earnings Per Share over the last 12 months.
Your assumption of the company's expected yearly EPS growth (e.g., 6 for 6%).
Pre-filled with the lower of median (33.2×) and current (51.5×) PE — the conservative anchor.
The annualized return you aim to achieve. We solve for the price that delivers it, then compare to today's price.
At 9.9% growth and a 33× exit, ₹2030 only delivers your return if you pay ₹897. The price is currently baking in 27% growth.
EPS grows 9.9%/yr for 5 years, then fades to 6% over 2, exits at 33×.
| Year | Growth | EPS (₹) |
|---|---|---|
| FY27 | 9.9% | 43.32 |
| FY28 | 9.9% | 47.61 |
| FY29 | 9.9% | 52.33 |
| FY30 | 9.9% | 57.51 |
| FY31 | 9.9% | 63.20 |
| FY32 | 8.0% ·fade | 68.22 |
| FY33 | 6.0% ·fade | 72.32 |
Methodology: we discount normalized net profit as a proxy for owner earnings (an earnings-power approximation — not full free cash flow). Terminal growth is capped at 6% (≈ nominal GDP) regardless of the required return. This is an analytical tool, not investment advice.
Guides on how to read this kind of business and the numbers that matter.